Geoffrey O. Coley is the International Business Head at MUFG Securities, where he is responsible for the oversight of the development, implementation, and operation of the front office functions.
Mr. Coley has over 30 years experience in financial services. He spent the majority of his career at Citigroup (1986–2007), where he held senior leadership roles for a significant proportion of his time with that firm. These included Co-Head of Global Fixed Income, Currencies and Commodities, Credit Markets, Head of US Investment Grade Origination, Syndication and Trading, Head of Investment Grade Secondary Trading, and Managing Director, Corporate Bond Trading. During his career, he has also held positions at Gleacher & Company, Citadel, Chapdelaine & Company, Salomon Brothers, and Kidder Peabody & Co.
Mr. Coley is an alumni of the University of New Hampshire, where he earned a B.S. degree in 1982. He was born in New York City and still resides there with his wife, Ann, and their three daughters.
Mr. Coley is the great-nephew of CRI’s founder, Helen Coley Nauts, and the great-grandson of Dr. William B. Coley, now recognized as the "Father of Cancer Immunotherapy."
He joined CRI’s board in 1998, and has long-standing involvement with a number of charitable organizations.
Let's spread the word about Immunotherapy! Click to share this page with your community.